Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3

<p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) is suggested to predict the radiosensitivity and/or prognosis of human esophageal squamous cell carcinoma (ESCC). The objective of this study was to investigate the efficacy of Nimotuzumab (an...

Full description

Bibliographic Details
Main Authors: Zhao Lei, He Li-Ru, Xi Mian, Cai Mu-Yan, Shen Jing-Xian, Li Qiao-Qiao, Liao Yi-Ji, Qian Dong, Feng Zi-Zhen, Zeng Yi-Xin, Xie Dan, Liu Meng-Zhong
Format: Article
Language:English
Published: BMC 2012-12-01
Series:Journal of Translational Medicine
Subjects:
EGFR
Esophageal squamous carcinoma cell
IGFBP-3
Nimotuzumab
Radiosensitivity
Online Access:http://www.translational-medicine.com/content/10/1/249

Internet

http://www.translational-medicine.com/content/10/1/249

Similar Items